Article
Utility of polygenic risk scores in diagnostic genetic testing for dilated cardiomyopathy
2026-01-22
Abstract excerpt
Dilated cardiomyopathy (DCM) is a major driver of heart failure and transplantation. Despite its strong genetic basis, clinical genetic testing identifies pathogenic/likely pathogenic (P/LP) variants in only about one-third of cases. Genome-wide association studies (GWAS) indicate that common variants also contribute to genetic risk, but utility of polygenic risk score (PRS) for diagnostic testing is unclear. We d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31562726-43e2-5a5b-93f5-fb3a27010290
- DOI
- 10.64898/2026.01.20.26344484
